Optimizing C3G Management: The Power of Lifestyle Changes and Supportive Care
On the Frontlines of C3GOptimizing C3G Management: The Power of Lifestyle Changes and Supportive Care
Patient Counseling in C3GN: From Disease Education to Shared Decision-Making
On the Frontlines of C3GPatient Counseling in C3GN: From Disease Education to Shared Decision-Making
Challenges in C3GN Care: Managing Relapsing and Treatment-Resistant Disease
On the Frontlines of C3GChallenges in C3GN Care: Managing Relapsing and Treatment-Resistant Disease
HIF-PHIs for Anemia in CKD: A Novel Treatment Approach
Clinician's RoundtableHIF-PHIs for Anemia in CKD: A Novel Treatment Approach
Patient-Centered Care for Anemia in CKD: Key Considerations for HIF-PHI Therapy
Clinician's RoundtablePatient-Centered Care for Anemia in CKD: Key Considerations for HIF-PHI Therapy
Anemia in CKD: Understanding the KDIGO 2025 Clinical Practice Guideline
Clinician's RoundtableAnemia in CKD: Understanding the KDIGO 2025 Clinical Practice Guideline
- advertisement
- advertisement
Upgrade Your Adult Patients’ IgAN Treatment
Medical Industry FeatureUpgrade Your Adult Patients’ IgAN Treatment
The Pathogenesis of Complement 3 Glomerulopathy (C3G)
Medical Industry FeatureThe Pathogenesis of Complement 3 Glomerulopathy (C3G)
The Endothelin System and IgAN: Emerging Evidence
Medical Industry FeatureThe Endothelin System and IgAN: Emerging Evidence
IgAN Insights: The Impact of Proteinuria
Medical Industry FeatureIgAN Insights: The Impact of Proteinuria
Unraveling IgA Nephropathy Pathogenesis: APRIL and the Four-Hit Cascade
Medical Industry FeatureUnraveling IgA Nephropathy Pathogenesis: APRIL and the Four-Hit Cascade
- 05/20/2025
- 05/16/2025
- 05/13/2025
- 05/08/2025
- 05/08/2025
- 04/23/2025
